3 stories found
An article explores the facts and misconceptions surrounding Amivantamab, a monoclonal antibody that has entered the battle against cancer. It aims to clarify its role and effectiveness in medical treatment.
A new drug, Amivantamab, has shown unprecedented results in clinical trials, completely eliminating cancer tumors in some patients who had previously exhausted other treatment options.
An international trial across 11 countries has shown that the Amivantamab vaccine produced a strong response in 15 patients with advanced cancer that had not responded to previous treatments.